Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ortho-McNeil Ultram

Executive Summary

FDA advisory committee discussion of scheduling status for tramadol is rescheduled for April 28. The Drug Abuse Advisory Committee will also evaluate the effectiveness of the independent steering committee in detecting and preventing Ultram abuse. The meeting will take place at the Gaithersburg, Md. Holiday Inn beginning at 8:30 a.m. The meeting was originally scheduled for Feb. 19 but was postponed to give the advisory committee time to review data ("The Pink Sheet" Feb. 16, In Brief). The committee will meet in closed session April 27...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS031797

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel